Skip to main navigation Skip to search Skip to main content

Epidemiology and management of infectious complications in contemporary management of chronic leukemias

Research output: Contribution to journal › Article › peer-review

Abstract

This is a review of the epidemiology and management of infectious complications in contemporary management of chronic leukemias. Patients with chronic leukemias typically are affected by nuisance infections due to the underlying hematologic condition, particularly hypogammaglobulinemia in CLL patients. With active treatment, particularly those agents that cause defects in cell-mediated immunity, the incidence of opportunistic infections increases although endogenous bacterial, mycobacterial, and fungal infections also occur. Exogenous treatment with immunoglobulin and antimicrobial prophylaxis, particularly anti-Pneumocystis prophylaxis, may be indicated in select patients. Routine vaccinations should be maintained in these patients and vaccination early in the course of treatment may result in improve protection.

Original languageEnglish (US)
Pages (from-to)3-10
Number of pages8
JournalInfectious Disorders - Drug Targets
Volume11
Issue number1
DOIs
StatePublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chronic granulocytic leukemia (CGL)
  • Chronic lymphoid leukemia (CLL)
  • Chronic myelogenous leukemia (CML)
  • Hypogammaglobulinemia
  • Opportunistic infection
  • Pneumocystis

Fingerprint

Dive into the research topics of 'Epidemiology and management of infectious complications in contemporary management of chronic leukemias'. Together they form a unique fingerprint.

Cite this